Klin Farmakol Farm. 2012;26(4):161-165

Unlicensed and off-label drug use in children

Petra Langerová1, Jiří Vrtal1, Jana Fürstová2
1 Ústav farmakologie LF UP a FN Olomouc
2 Katedra matematické analýzy a aplikací matematiky, Přírodovědecká fakulta Univerzity Palackého v Olomouci

Many common drugs have not been registered for use in children or their prescription for children is limited to a certain age. Therefore, they

are sometimes prescribed as unlicensed (drugs unregistered for children) or off-label (prescribed for children younger than those for whom the

drug is registered). In this study, we evaluated the incidence of this type of prescription for medicinal products prescribed by the Department

of Pediatrics, University Hospital Olomouc in a period of 3 months. A total of 4,174 prescriptions for 2,100 children were evaluated. Unlicensed

or off-label drugs were found in 8.62 % of prescriptions. Unlicensed prescriptions were significantly more common in boys than in girls. The

prescription of unlicensed drugs was significantly more frequent in school age children than in any other age group. The most commonly

prescribed unlicensed drugs were ACE inhibitors; among off-label drugs, antihistamines and bronchodilators were most frequently prescribed.

Keywords: off-label, unlicensed, drugs, children, pediatrics, prescriptions, hospital

Published: December 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Langerová P, Vrtal J, Fürstová J. Unlicensed and off-label drug use in children. Klin Farmakol Farm. 2012;26(4):161-165.
Download citation

References

  1. Chessels JM. Treatment of childhood acute lymphoblastic leukaemia: present issues and future prospects. Blood Rev 1992; 6: 193-203. Go to original source... Go to PubMed...
  2. Roberts R, Rodriguez W, Murphy D, Crescenzi T. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies. JAMA. 2003; 290(7): 905-911. Go to original source... Go to PubMed...
  3. Caldwell PH, Murphy SB, Butow PN, Craig JC. Clinical trials in children. Lancet. 2004; 364(9436): 803-811. Go to original source... Go to PubMed...
  4. Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr. 2005; 164(9): 552-558. Go to original source... Go to PubMed...
  5. Langerová P, Urbánek K. Používání léků mimo schválené indikace v pediatrii. Čes-slov Pediat 2011; 66(6): 380-386.
  6. Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ. 1998; 316(7128): 343-345. Go to original source... Go to PubMed...
  7. Kemper EM, Merkus M, Wierenga PC, Van Rijn PC, Van der Werff D, Lie-A-Huen L, Offringa M. Towards evidence-based pharmacotherapy in children. Paediatr Anaesth. 2011; 21(3): 183-189. Go to original source... Go to PubMed...
  8. Lindell-Osuagwu L, Korhonen MJ, Saano S, Helin-Tanninen M, Naaranlahti T, Kokki H. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature. J Clin Pharm Ther. 2009; 34(3): 277-287. Go to original source... Go to PubMed...
  9. Hsien L, Breddemann A, Frobel AK, Heusch A, Schmidt KG, Läer S. Off-label drug use among hospitalised children: identifying areas with the highest need for research. Pharm Sci. 2008; 30(5): 497-502. Go to original source... Go to PubMed...
  10. Adámková V, a kol. Hypertenze u dětí a mladistvých (Abstrakt). Sborník abstrakt, 26. pracovní dny dětské nefrologie v Českém Krumlově 21.-22. října 2005.
  11. Fišerová H. Akutní a recidivující respirační onemocnění u dětí. Pediatr. pro Praxi 2008; 9(1): 25-31.
  12. Del Cuvillo A, Sastre J, Montoro J, Jáuregui I, Ferrer M, Dávila I, Bartra J, Mullol J, Valero A. Use of antihistamines in pediatrics. J Investig Allergol Clin Immunol. 2007; 17(Suppl 2): 28-40.
  13. Khdour MR, Hallak HO, Alayasa KS, AlShahed QN, Hawwa AF, McElnay JC. Extent and nature of unlicensed and off-label medicine use in hospitalised children in Palestine. Int J Clin Pharm. 2011; 33(4): 650-655. Go to original source... Go to PubMed...
  14. Strnadová V. O čem se diskutuje v oblasti klinických studií. Klin Farmakol Farm 2007; 21(3-4): 119-121.
  15. European Medicines Agency. The European paediatric initiative: History of the Paediatric Regulation. Doc. Ref: EMEA/17967/04 Rev 1, London 2007.




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.